Other Titles
Nursing Outcomes Based on Data [Session]
Abstract
Session presented on Sunday, November 8, 2015:
Significance and Background: Pressure ulcers are acquired among high-risk patients in pediatric and adult hospitals, and are key indicators of the effectiveness of care. The NPUAP 1 recognizes that PUs can occur on any tissue under pressure, including beneath medical devices (MDs) used for diagnostic/therapeutic purposes. In the past two years we have reduced our quarterly prevalence of PUs (sacral, coccyx, and heel) to zero to 0.3% using an EB Skin Bundle 5 plus a 5-Layered Silicone Border Dressing thus the direct impact of MDR PUs has become more transparent. Stage III, IV, and Unstageable PUs are reportable as sentinel events, and are linked with litigation and lack of Medicare/Medicaid reimbursement. In 2012, using our CALNOC (Collaborative Alliance for Nursing Outcomes) nurse indicator PU data, we found a surge of MDR PUs benchmark in Pediatrics and Adult units, (5-Tracheostomy; 2-Noninvasive Ventilation Masks (NIVM); 1-IV Hub). Thus as we strive to be a high-reliability organization, we have intensified efforts to improve safety through better process re-design, changing practice to EB therapies (1-4) and building a culture of safety.
Purpose: The aim of this Interprofessional performance improvement (PI) project, was to examine our on-going rate of medical device related (MDR) pressure ulcers (PUs) among pediatric and adult patients; and to institute a novel PI program for MDR PU prevention, based on evidence and innovation.
Methods: The adult/pediatric advance practice nurses and the director of nursing research, convened an interprofessional team (staff nurses; MDs; PT; PI nurses; wound care specialist) who reviewed the literature, and a subsequent development of an intervention model using a rapid-cycle, Plan-Do-Study-Act (PDSA) framework. A root cause analysis of all 8 MDR PUs in 2012 was conducted reviewing stage, location, device involved, and compliance with our standard SKIN Bundle. (4) Because of the urgency to reduce NIVM and tracheostomy-related MDR PUs, we immediately (2 nd Q, 2012), deployed the use of Mepilex Transfer or Lite, beneath all tracheostomy neck plates and NIVM. We finalized our comprehensive MDR Prevention Model (2013), to include a new MDR PU Prevention Bundle 1,3,4 with EB interventions, including frequent skin/device assessments, moisture -reducing device interface and pressure-free device interface.
Evaluation and Discussion: Our MDR Prevention Model was fully launched in 3 rd quarter, 2013. We've closely tracked point-prevalence/and incidence data, along team compliance with the MDR prevention bundle for the past 3 Quarters. There was an absolute reduction of MDR PUs from 0.06% incidence of stage 3+ MDR HAPU's per 1000 patient days to zero in pediatrics (benchmark 0.0 - 0.04%); and among adults from 0.28% incidence to zero with (benchmark 0.05-0.09 %,). Thus, through interprofessional team implementation of the MDR prevention program, and deployment of EB therapies to relieve pressure at the device-skin interface effectively, (1,3,4,5), rigorous education and continuous monitoring, we have sustained a 'zero' incidence among adults and pediatric patients. These interventions can be integrated into daily workflow and result in sustained effect on nursing practice, teamwork and patient outcomes.
Sigma Membership
Iota Eta
Type
Presentation
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Pressure Ulcers, Lean, Evidence Based Model
Recommended Citation
Kalowes, Peggy; Paige, Raquel; and Messina, Valerie, "Reducing device-related pressure ulcers: Leveraging data and innovation to improve adult/pediatrics outcomes" (2016). Convention. 263.
https://www.sigmarepository.org/convention/2015/presentations_2015/263
Conference Name
43rd Biennial Convention
Conference Host
Sigma Theta Tau International
Conference Location
Las Vegas, Nevada, USA
Conference Year
2015
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Reducing device-related pressure ulcers: Leveraging data and innovation to improve adult/pediatrics outcomes
Las Vegas, Nevada, USA
Session presented on Sunday, November 8, 2015:
Significance and Background: Pressure ulcers are acquired among high-risk patients in pediatric and adult hospitals, and are key indicators of the effectiveness of care. The NPUAP 1 recognizes that PUs can occur on any tissue under pressure, including beneath medical devices (MDs) used for diagnostic/therapeutic purposes. In the past two years we have reduced our quarterly prevalence of PUs (sacral, coccyx, and heel) to zero to 0.3% using an EB Skin Bundle 5 plus a 5-Layered Silicone Border Dressing thus the direct impact of MDR PUs has become more transparent. Stage III, IV, and Unstageable PUs are reportable as sentinel events, and are linked with litigation and lack of Medicare/Medicaid reimbursement. In 2012, using our CALNOC (Collaborative Alliance for Nursing Outcomes) nurse indicator PU data, we found a surge of MDR PUs benchmark in Pediatrics and Adult units, (5-Tracheostomy; 2-Noninvasive Ventilation Masks (NIVM); 1-IV Hub). Thus as we strive to be a high-reliability organization, we have intensified efforts to improve safety through better process re-design, changing practice to EB therapies (1-4) and building a culture of safety.
Purpose: The aim of this Interprofessional performance improvement (PI) project, was to examine our on-going rate of medical device related (MDR) pressure ulcers (PUs) among pediatric and adult patients; and to institute a novel PI program for MDR PU prevention, based on evidence and innovation.
Methods: The adult/pediatric advance practice nurses and the director of nursing research, convened an interprofessional team (staff nurses; MDs; PT; PI nurses; wound care specialist) who reviewed the literature, and a subsequent development of an intervention model using a rapid-cycle, Plan-Do-Study-Act (PDSA) framework. A root cause analysis of all 8 MDR PUs in 2012 was conducted reviewing stage, location, device involved, and compliance with our standard SKIN Bundle. (4) Because of the urgency to reduce NIVM and tracheostomy-related MDR PUs, we immediately (2 nd Q, 2012), deployed the use of Mepilex Transfer or Lite, beneath all tracheostomy neck plates and NIVM. We finalized our comprehensive MDR Prevention Model (2013), to include a new MDR PU Prevention Bundle 1,3,4 with EB interventions, including frequent skin/device assessments, moisture -reducing device interface and pressure-free device interface.
Evaluation and Discussion: Our MDR Prevention Model was fully launched in 3 rd quarter, 2013. We've closely tracked point-prevalence/and incidence data, along team compliance with the MDR prevention bundle for the past 3 Quarters. There was an absolute reduction of MDR PUs from 0.06% incidence of stage 3+ MDR HAPU's per 1000 patient days to zero in pediatrics (benchmark 0.0 - 0.04%); and among adults from 0.28% incidence to zero with (benchmark 0.05-0.09 %,). Thus, through interprofessional team implementation of the MDR prevention program, and deployment of EB therapies to relieve pressure at the device-skin interface effectively, (1,3,4,5), rigorous education and continuous monitoring, we have sustained a 'zero' incidence among adults and pediatric patients. These interventions can be integrated into daily workflow and result in sustained effect on nursing practice, teamwork and patient outcomes.
Description
43rd Biennial Convention 2015 Theme: Serve Locally, Transform Regionally, Lead Globally.